Jilin Jian Yisheng Pharmaceutical Co Ltd Cash Flow Quality Index
Jilin Jian Yisheng Pharmaceutical Co Ltd cash flow quality index. Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Cash Flow Quality Index of 1.53x as of September 2025. Operating cash flow of CN¥8.20 Million exceeds net income of CN¥5.36 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Jilin Jian Yisheng Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jilin Jian Yisheng Pharmaceutical Co Ltd (2008–2025)
Cash flow quality index of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2008 to 2025. Historical Cash Flow Quality Index for Jilin Jian Yisheng Pharmaceutical Co Ltd across 18 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 002566 equity financing ratio to measure how much of total assets are equity-financed.
Jilin Jian Yisheng Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2008–2025)
Jilin Jian Yisheng Pharmaceutical Co Ltd cash flow quality index by year from 2008 to 2025. Year-by-year earnings quality comparison for Jilin Jian Yisheng Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Jilin Jian Yisheng Pharmaceutical Co Ltd generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.40x | CN¥98.74 Million | CN¥29.00 Million | ▲ +192.6% |
| 2024 | 1.16x | CN¥58.94 Million | CN¥50.66 Million | ▼ -47.3% |
| 2023 | 2.21x | CN¥209.13 Million | CN¥94.73 Million | ▲ +33.7% |
| 2022 | 1.65x | CN¥145.86 Million | CN¥88.32 Million | ▼ -19.6% |
| 2021 | 2.05x | CN¥215.10 Million | CN¥104.70 Million | ▼ -9.5% |
| 2020 | 2.27x | CN¥203.51 Million | CN¥89.61 Million | ▼ -0.6% |
| 2019 | 2.28x | CN¥210.87 Million | CN¥92.33 Million | ▲ +15.9% |
| 2018 | 1.97x | CN¥167.32 Million | CN¥84.91 Million | ▼ -39.7% |
| 2017 | 3.27x | CN¥270.65 Million | CN¥82.80 Million | ▲ +412.5% |
| 2016 | -1.05x | CN¥-17.52 Million | CN¥16.75 Million | ▲ +96.6% |
| 2015 | -30.84x | CN¥-324.29 Million | CN¥10.51 Million | ▼ -401.7% |
| 2014 | -6.15x | CN¥-592.06 Million | CN¥96.31 Million | ▼ -185.4% |
| 2013 | -2.15x | CN¥-188.45 Million | CN¥87.50 Million | ▼ -365.0% |
| 2012 | 0.81x | CN¥79.08 Million | CN¥97.31 Million | ▲ +170.2% |
| 2011 | -1.16x | CN¥-112.12 Million | CN¥96.79 Million | ▼ -300.0% |
| 2010 | 0.58x | CN¥50.73 Million | CN¥87.60 Million | ▼ -71.7% |
| 2009 | 2.05x | CN¥125.25 Million | CN¥61.10 Million | ▲ +313.6% |
| 2008 | 0.50x | CN¥20.50 Million | CN¥41.36 Million | — |